Khalid Saad Alharbi
Overview
Explore the profile of Khalid Saad Alharbi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alharbi K, Alenezi S, Alsahli T, Afzal M, Mantargi M, Kazmi I, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Mar;
PMID: 40056204
Cyclophosphamide is a widely used chemotherapeutic agent known for its effectiveness in treating various cancers; however, it is associated with significant immunosuppressive side effects. This study investigates the potential of...
2.
Rafeeq M, Al-Abbasi F, Afzal M, Alharbi K, Moglad E, Al-Qahtani S, et al.
Curr Neuropharmacol
. 2025 Feb;
PMID: 39949093
Aim: The investigation aimed to study the outcome of rosiridin in Parkinson's disease (PD) induced by rotenone (ROT) in rodents. Methods: Rodents were randomized into IV groups and were induced...
3.
Alharbi K, Afzal M, Al-Abbasi F, Moglad E, Al-Qahtani S, Almalki N, et al.
Sci Rep
. 2025 Jan;
15(1):3076.
PMID: 39856142
Europinidin is a novel anthocyanidin found in the petals of Plumbago europea that exhibits several physiological effects. Research was conducted to assess europinidin's cardioprotective efficacy in a diabetic and myocardial...
4.
Kazmi I, Altayb H, Al-Abbasi F, Alharbi K, Almalki N, Moglad E, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39621090
The present investigation determines the effects of rosiridin in cisplatin (CP)-induced renal toxicity in rats. The experimental animals were used and divided into four groups. Experimental rats were randomly divided...
5.
Alqarni S, Afzal M, Alharbi K, Alenezi S, Alsahli T, Zaidi S, et al.
Medicina (Kaunas)
. 2024 Nov;
60(11).
PMID: 39596997
Rosiridin is a monoterpene with outstanding monoamine inhibitory activity that is useful to treat depressive episodes and rapid-onset dementia. The current investigation aims to evaluate the neurologically protective impact of...
6.
Alharbi K
Pathol Res Pract
. 2024 Oct;
263:155641.
PMID: 39395297
Parkinson's Disease is a highly complicated neurological disorder, with a key manifestation of loss of dopaminergic neurons. Despite the plethora of medicines that alleviate the symptoms, there is an urgent...
7.
Altyar A, Afzal M, Ghaboura N, Alharbi K, Alenezi S, Sayyed N, et al.
Pharmaceuticals (Basel)
. 2024 Jun;
17(6).
PMID: 38931365
Background: Epilepsy is defined by an excessive level of activity in the neurons and coordinated bursts of electrical activity, resulting in the occurrence of seizure episodes. The precise cause of...
8.
Imam F, Mukhopadhyay S, Kothiyal P, Alshehri S, Alharbi K, Afzal M, et al.
Saudi Pharm J
. 2024 Apr;
32(5):102048.
PMID: 38585197
Memory loss or dementia is a progressive disorder, and one of its common forms is Alzheimer's disease (AD), effecting mostly middle aged and older adults. In the present study, we...
9.
Alharbi K
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540238
Huntington's disease (HD) is a neurodegenerative disease that causes progressive motor and cognitive dysfunction. There is no cure for HD, and current therapeutics can only manage the signs and symptoms...
10.
Alharbi K
Pathol Res Pract
. 2024 Feb;
255:155170.
PMID: 38324964
Hepatitis is a worldwide health issue that causes inflammation of the liver and is frequently brought on by viral infections, specifically those caused by the hepatitis B and C viruses....